Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2013-01-15
2014-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-level Laser Therapy as an Adjunct to Non-surgical Periodontal Treatment
NCT05233501
Efficacy of Laser Therapy for Periodontitis
NCT07013162
Diode Laser Application With Non-Surgical Periodontal Treatment
NCT04908098
Periodontal Treatment With Diode Laser in the Patients With Diabetes Melitus
NCT03444363
Effect of Periodontal Therapy on Biomarkers in Periodontitis
NCT05005923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the light of the current knowledge, the impaired wound healing seen in diabetic patients may be a reason to require an additional approach in periodontal treatment like biostimulation of periodontal tissues by several ways. In order to determine the healing response, the investigators aimed to evaluate the effects of LBT irradiation with Nd-YAG laser at the 1064-nm wavelength as an adjunct to non-surgical periodontal treatment (NSPT) by means of periodontal clinical measurements and gingival crevicular fluid cytokine levels (IL-1β and IL-10) in systemically healthy and uncontroled DM2 patients with generalized periodontitis .
The study was designed as a split-mouth randomized, controlled, double-blind clinical study. The study protocol was approved by the Local Ethics Committee of Ondokuz Mayıs University and Turkey Ministry of Health, Drug and Medical Device Agency . The written informed consent was obtained from all study participants in accordance with the Helsinki Declaration .
All participants with periodontitis received NSPT. Non-surgical periodontal treatment consisted of conventional quadrant scaling in four session of 30 min, each on a weekly basis, using scalers, curettes and ultrasonic devices.
Laser Biostimulation treatment (LBT) and Sham application: Following NSPT, either the left or right side of each periodontitis patient was randomly selected (by coin toss) to receive LBT or sham treatment. LBT was performed six times (on the same day 30 which was the last scalling and root planning session and repeated weekly for 5 more times) using a 1064 nm Nd.YAG laser (Fotona AT Fidelis III,Ljubljana, Slovenia).
Clinical Measurements and Gingival creviculat fluid (GCF) Sampling Clinical measurements were performed before NSPT (baseline) and on days 30, 37 and 72 of the follow-up for both DM2 and SH groups. The following clinical periodontal measurements were recorded Silness \& Löe plaque index (PI), Löe \& Silness gingival index(GI), probing pocket depth (PPD); clinical attachment level (CAL); bleeding on probing (BOP). A Williams periodontal probe (Nordent Manufacturing Inc., Elk Grove Village, IL, USA) calibrated in mm was used to measure 6 sites on each selected tooth (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual locations). For each tooth, the side with the highest PPD and CAL values were identified, and the additional clinical measurements and GCF sampling were performed on this side in both LBT and sham application of the patients. (total: 30 teeth in DM2 group, 30 teeth in SH group). GCF samples were collected before NSPT treatment(baseline) and on Days 30, 37 and 72 of follow-up. Sampling sites were isolated with cotton rolls, saliva was removed, and supragingival plaque, if present, was removed using a sterile curette. GCF was sampled by placing a strip of filter paper (Periopaper, ProFlow, Inc., Amityville, New York, USA) into the crevice until mild resistance was felt and then leaving it in position for 30 seconds. The GCF volume of each strip was determined by electronic impedance (Periotron 8000, ProFlow, Inc.), and samples were then placed in sterile polypropylene tubes and stored at -70°C until analysis.
Amounts of IL-1β and IL-10 in each GCF sample were evaluated using standard enzyme-linked immunosorbent assays (ELISA) according to the manufacturers' instructions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
periodontal therapy
Systemically healthy subjects with periodontitis that have the sides treated with non-surgical periodontal treatment (NSPT) split-mouth designed study
No interventions assigned to this group
periodontal+laser therapy
Systemically healthy subjects with periodontitis that have the contra-lateral sides treated with laser biostimulation therapy(LBT) adjunct to non-surgical periodontal treatment(NSPT) split-mouth designed study
No interventions assigned to this group
diabetic periodontal therapy
Type 2 diabetic(DM2) subjects with periodontitis that have the sides treated with non-surgical periodontal treatment (NSPT) split-mouth designed study
No interventions assigned to this group
diabetic periodontal+laser therapy
Type 2 diabetic(DM2) subjects with periodontitis that have the contra-lateral sides treated with laser biostimulation therapy(LBT) adjunct to non-surgical periodontal treatment (NSPT) split-mouth designed study
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Having been diagnosed as type 2 diabates mellitus (DM2) with the ADA criteria at least 2 years before the study and having an HbA1c value of ≥ 7 for DM2 group,
3. Not having a systemic disease other than DM2 for diabetic group; and not having any systemical diseases for systemically healthy group,
4. Not having any systemic complications of diabetes,
5. Not smoking or consuming alcohol,
6. Having at least 20 teeth,
7. Having at least two single-rooted teeth (like one premolar or incisor tooth) representing symmetrical or same group teeth with gingival index≥2, bleeding on probing (+), probing pocket depth and/or clinical attachment lvel \>5 mm as well as ≥30% radiographically observable alveolar bone loss, on the left and right area of mandibular,
8. Being able to fulfill the instructions for oral hygiene training
Exclusion Criteria
2. received periodontal treatment in the 6 months prior to data collection
3. having predisposing factors such as a dental crown, bridge, filling, or cavity on teeth from which the GCF was to be collected.
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ondokuz Mayıs University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
muge lutfioglu
Associate Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OMU KAEK2012/49
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.